Work

Abstract LB273: HSK46575: A best-in-class, long lasting, small molecular CYP11A1 inhibitor for the treatment of castration-resistant prostate cancer (CRPC)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb273

Authors: Lulin Huang, Meilin Qian, Ju Wang, Yao Li, Pingming Tang, Pangke Yan

Institution: Haisco Pharmaceutical Group Co., Ltd. (China)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409820966

Cites:

Cited by:

Related to: 10